February 10, 2011 – For the first time in the UK, cancer patients are starting to receive treatment with Novalis Tx radiosurgery. This device, by Brainlab and Varian Medical Systems, gives the chance of a cure to those with inoperable tumors and offers the possibility to perform precise, painless treatment in a single patient visit.

The system makes it possible for doctors to treat patients with tumors virtually anywhere in the body in just a single session. Combining a 'sat nav' like targeting system and powerful treatment beams, it can destroy cancerous cells and helps to protect surrounding healthy tissue. Treatment is also made more patient-friendly by delivering frameless radiosurgery for brain tumors, an alternative to techniques that require immobilization with an invasive head ring that is affixed to the skull.

In its first year of operation at the brand new Clatterbridge Cancer Centre in Liverpool, it is expected to treat more than 800 cancer patients. It is estimated that 150 of these patients will be priority brain tumor patients where precise, non-invasive treatment is particularly effective.

"Unlike some other highly specialized radiation treatment machines, the Novalis Tx can treat many different types of cancer in all over the body allowing us to treat more cancer patients with a single device,” said Brian Haylock, consultant oncologist and clinical director for radiotherapy at Clatterbridge Centre for Oncology. “This coupled with the speed with which we can treat patients - in some cases in as little as 15 minutes in just one session - means the equipment will be available for the benefit of more patients here in the UK."

Later this year, Novalis Tx machines will become operational at two other specialist NHS cancer centers in Edinburgh and Manchester.

For more information: www.brainlab.com, www.varian.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 30, 2024 — RaySearch Laboratories AB announced the release of the latest version of RayCare, the next generation ...

Time May 30, 2024
arrow
Subscribe Now